New implant for addiction treatment tested in healthy volunteers
Knowledge-focused
Recruiting now
This early-stage study tests a new implant (BICX104) that slowly releases naltrexone over 3 months. It involves 30 healthy adults to check safety and how the drug moves in the body, comparing it to a standard monthly shot (Vivitrol). Some groups also take bupropion pills. The goa…
Phase: PHASE1 • Sponsor: BioCorRx Pharmaceuticals Inc • Aim: Knowledge-focused
Last updated May 26, 2026 07:50 UTC